Concepedia

Sujatha Selvaraju

SS

Statistics

Publications

3

Citations

295

H-Index

3

Active since

2017

Affiliations

AbbVie (United States)(Current)

Sujatha Selvaraju is an author at AbbVie (United States) specializing in life sciences, protein-protein interaction inhibitor design, and drug discovery.

Publications per year

2017–2017

3

Publications

3

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin et al. · Nature Chemical Biology · 2017 · 233 citations · Full text

, , +9

Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

Julie L. Wilsbacher, Min Cheng, Dong Cheng et al. · Molecular Cancer Therapeutics · 2017 · 32 citations · Full text

, , +13

SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding

Michael L. Curtin, Marina Pliushchev, Huan‐Qiu Li et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 30 citations · Full text

, , +15

1–3 of 3